LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS

Today’s Daily Dose brings you news about Lilly temporarily halting phase III trial of COVID-19 antibody, Gossamer Bio’s oral GB001 flunking in both asthma and chronic rhinosinusitis trials, encouraging data from Regeneron/Sanofi’s Dupixent trial, and Johnson & Johnson’s rosy outlook. … Read more…

AZN Pauses COVID-19 Vaccine Trial, ALBO Hits New High, CRBP Plunges, PFE To Invest In TRIL

Today’s Daily Dose brings you news about AstraZeneca pausing its phase 3 study of COVID-19 vaccine candidate, Albireo’s positive data from phase 3 trial of Odevixibat in progressive familial intrahepatic cholestasis, Corbus’ disappointing results from its phase 3 trial of … Read more…

WHO pauses trial of hydroxychloroquine as coronavirus treatment amid safety concerns

Hydroxychloroquine, which Trump has repeatedly touted as a potential game changer in fighting the coronavirus, is an anti-malarial drug that’s also used by doctors to treat rheumatoid arthritis and lupus. Health and Science U.S.HEALTHCARE UPDATE: SPECIAL NEWS UPDATE: Click today … Read more…